Roche MagNA Pure 24 Instrument

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation will not be issued. The solicitation number for this requirement is 2023-79157 and is hereby issued as a Request for Quotation (RFQ) using FAR Subpart 13.1 Simplified Acquisition Procedures. The Centers for Disease Control and Prevention intends to award a firm-fixed price purchase order for the following requirement. Please either fill in the dollar amounts for each line item and total, or provide a separate Excel spreadsheet containing the same information, inclusive of line item numbers, quantities, and unit of measure. Line Item Part Number Supplies/Services Quantity/Unit Unit Price Extended Price 0001 0729051 MagNA Pure 24 Instrument 1 / EA $ $ 0002 05107393001 RAS Training/Installation 1 / EA $ $ 0003 000000000 Shipping Charges 1 / EA $ $ Total Price $ The quote format is at the discretion of the offeror. It is the offeror's responsibility to be familiar with the applicable clauses and provisions. Clauses and provisions maybe accessed via the Internet at: www.acquisition.gov/far. This solicitation document and incorporated provisions and clauses are those in effect through the Federal Acquisition Circular (FAC) 2023-04 (June 02, 2023). A firm-fixed price purchase order will be issued in writing to the successful offeror. To be eligible to receive an award resulting from this solicitation, contractor must be registered in the System for Award Management. To register, apply via the Internet at www.sam.gov. For questions on registration, contact Federal Service Desk at 866-606-8220. Include FAR 52.212-3, Offeror Representations and Certifications, with offer; or indicate if it is available online at SAM.gov. No telephonic quotes will be processed or accepted. All responses must be received no later than 2:00pm Eastern on Wednesday August 30, 2023. Any and all questions must be submitted in writing and should be directed to Tiffney Griner-Esslinger at tesslinger@cdc.gov. ATTACHMENTS: 1. Brand-Name Only Justification 2. Provisions and Clauses